Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Stockholders Equity of -$387.0 thousand for fiscal year 2025.
ACRO BIOMEDICAL CO., LTD. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$387.0K | -31.2% |
| 2024 | -$295.0K | -14.8% |
| 2023 | -$257.0K | -152.8% |
| 2022 | $486.4K | -24.4% |
| 2021 | $643.7K | -6.1% |
| 2020 | $685.9K | -14.1% |
| 2019 | $798.2K | -8.6% |
| 2019 | $873.7K | -25.2% |
| 2018 | $1.17M | -6.0% |
| 2018 | $1.24M | +142.9% |
| 2017 | $511.3K | +3556.6% |
| 2016 | -$14.8K | -151.7% |
| 2015 | $28.6K | +629.6% |
| 2014 | $3.9K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$432.6K | -51.5% | -36.2% |
| June 30, 2025 | -$317.5K | -14.9% | -4.5% |
| March 31, 2025 | -$303.9K | -13.7% | -3.0% |
| December 31, 2024 | -$295.0K | -14.8% | -3.3% |
| September 30, 2024 | -$285.5K | -19.2% | -3.3% |
| June 30, 2024 | -$276.4K | -181.4% | -3.4% |
| March 31, 2024 | -$267.3K | -165.1% | -4.0% |
| December 31, 2023 | -$257.0K | -152.8% | -7.3% |
- ACRO BIOMEDICAL CO., LTD. showed a decrease of -31.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2014–2025 period, ACRO BIOMEDICAL CO., LTD.’s stockholders equity has declined by 9959.0% (from $3.9 thousand to -$387.0 thousand).
- The most recent figure is from ACRO BIOMEDICAL CO., LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: